IDEXX Laboratories Announces Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
IDEXX (IDXX) Oversold, Buy on Weakness - Stifel
August 1, 2017 12:31 PM EDTStifel analyst Jonathan Block sees shares of IDEXX Laboratories (NASDAQ: IDXX) as oversold and reiterated a Buy rating and price target of $185.
Block called the quarter "solid" with a raised outlook but notes shares are under pressure as the magnitude of the beat and... More



